Document is current
Any future updates will be listed below
-
Authors
Habib, Naomi https://orcid.org/0000-0002-6049-2487
McCabe, Cristin
Medina, Sedi
Varshavsky, Miriam
Kitsberg, Daniel
Dvir-Szternfeld, Raz
Green, Gilad
Dionne, Danielle https://orcid.org/0000-0002-8338-4323
Nguyen, Lan
Marshall, Jamie L. https://orcid.org/0000-0002-2364-391X
Chen, Fei
Zhang, Feng
Kaplan, Tommy https://orcid.org/0000-0002-1892-5461
Regev, Aviv https://orcid.org/0000-0003-3293-3158
Schwartz, Michal https://orcid.org/0000-0003-4015-7507
- License Information
-
More Information
Article History
Received: 24 April 2019
Accepted: 18 March 2020
First Online: 27 April 2020
Competing interests
: A.R. is a founder and equity holder of Celsius Therapeutics, an equity holder in Immunitas Therapeutics and an SAB member of Syros Pharmaceuticals, Thermo Fisher Scientific, Neogene Therapeutics and Asimov. The other authors declare no competing interests.
